Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression

Simvastatin inhibits 3-hydroxy-3-methylglutaryl CoA reductase, the rate-limiting enzyme in the cholesterol biosynthetic pathway, and is widely used to control plasma cholesterol levels and prevent cardiovascular disease. However, emerging evidence indicates that the beneficial effects of simvastatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Tainaê, Baungratz, Monaliza Marizete, Haskel, Suellen Priscila, de Lima, Daniela Delwing, da Cruz, Júlia Niehues, Magro, Débora Delwing Dal, da Cruz, José Geraldo Pereira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464062/
https://www.ncbi.nlm.nih.gov/pubmed/23055736
http://dx.doi.org/10.2147/NDT.S31714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464062/
https://www.ncbi.nlm.nih.gov/pubmed/23055736
http://dx.doi.org/10.2147/NDT.S31714

Ejemplares similares